Home / Investors Information / EDAP Successfully Expands HIFU Business and Approval in New Territories Read more about EDAP Successfully Expands HIFU Business and Approval in New Territories EDAP Reports Second Quarter 2009 Financial Results Read more about EDAP Reports Second Quarter 2009 Financial Results EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys Read more about EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys EDAP Announces Webcast and Conference Call of Second Quarter 2009 Results Read more about EDAP Announces Webcast and Conference Call of Second Quarter 2009 Results EDAP Announces New Board Member Read more about EDAP Announces New Board Member EDAP Expands U.S. ENLIGHT Clinical Trial Team to Accelerate Patient Enrollment Read more about EDAP Expands U.S. ENLIGHT Clinical Trial Team to Accelerate Patient Enrollment EDAP Appoints U.S. Urologist Dr. Argil Wheelock to Board of Directors Read more about EDAP Appoints U.S. Urologist Dr. Argil Wheelock to Board of Directors EDAP Highlights HIFU Focal Therapy for Treatment of Prostate Cancer Read more about EDAP Highlights HIFU Focal Therapy for Treatment of Prostate Cancer EDAP Expands HIFU Business in South America Read more about EDAP Expands HIFU Business in South America EDAP Reports First Quarter 2009 Financial Results Read more about EDAP Reports First Quarter 2009 Financial Results Pagination First page « First Previous page ‹ Previous … Page 38 Page 39 Page 40 Page 41 Current page 42 Page 43 Page 44 Page 45 Page 46 … Next page Next › Last page Last » Subscribe to
EDAP Successfully Expands HIFU Business and Approval in New Territories Read more about EDAP Successfully Expands HIFU Business and Approval in New Territories
EDAP Reports Second Quarter 2009 Financial Results Read more about EDAP Reports Second Quarter 2009 Financial Results
EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys Read more about EDAP Receives U.S. FDA 510(k) Approval for Sonolith I-Sys
EDAP Announces Webcast and Conference Call of Second Quarter 2009 Results Read more about EDAP Announces Webcast and Conference Call of Second Quarter 2009 Results
EDAP Expands U.S. ENLIGHT Clinical Trial Team to Accelerate Patient Enrollment Read more about EDAP Expands U.S. ENLIGHT Clinical Trial Team to Accelerate Patient Enrollment
EDAP Appoints U.S. Urologist Dr. Argil Wheelock to Board of Directors Read more about EDAP Appoints U.S. Urologist Dr. Argil Wheelock to Board of Directors
EDAP Highlights HIFU Focal Therapy for Treatment of Prostate Cancer Read more about EDAP Highlights HIFU Focal Therapy for Treatment of Prostate Cancer
EDAP Expands HIFU Business in South America Read more about EDAP Expands HIFU Business in South America
EDAP Reports First Quarter 2009 Financial Results Read more about EDAP Reports First Quarter 2009 Financial Results
